are compound glp 1 safe Affordability and Safety: How Hims & Hers is Delivering a New GLP-1 Experience Through the Scale of Our Platform From Lab to Last Mile:
Description
A case-control study from March 2023 found that there was a significant positive correlation with the presence of increased retained gastric contents, determined by esophagogastroduodenoscopy (EGD), in patients on GLP-1 agonists compared to control (5.4% to 0.5%)
GLP-1 receptor agonists are a class of medications that help control blood glucose (blood sugar) levels and support weight management
Four key questions on the new wave of anti-obesity drugs
The major players in the obesity GLP-1 market include Novo Nordisk A/S, Eli Lilly and Company, Amgen, Viking Therapeutic, AstraZeneca, Roche (Carmot Therapeutics), Boehringer Ingelheim, Pfizer Inc., Altimmune, Inc., and Structure Therapeutics
Archived from the original on 5 February 2023
Phung OJ, Scholle JM, Talwar M, Coleman CI
